Publicaciones en las que colabora con SILVIA ORTEGA GUTIÉRREZ (47)

2022

  1. New Trends in Aging Drug Discovery

    Biomedicines, Vol. 10, Núm. 8

  2. Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice

    Journal of Medicinal Chemistry, Vol. 65, Núm. 16, pp. 10956-10974

2021

  1. Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome

    ACS Central Science, Vol. 7, Núm. 8, pp. 1300-1310

2020

  1. A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2372-2390

2019

  1. A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia

    Journal of Medicinal Chemistry, Vol. 62, Núm. 13, pp. 6035-6046

  2. Blocking Ras inhibition as an antitumor strategy

    Seminars in Cancer Biology, Vol. 54, pp. 91-100

2018

  1. Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT 1A Receptor in Native Cells of the Immune System

    Bioconjugate Chemistry, Vol. 29, Núm. 6, pp. 2021-2027

  2. 2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs

    GLIA, Vol. 66, Núm. 7, pp. 1447-1463

  3. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells

    Bioconjugate Chemistry, Vol. 29, Núm. 2, pp. 382-389

  4. Monoacylglycerol lipase (MAGL) as a promising therapeutic target

    Biochemical Pharmacology, Vol. 157, pp. 18-32

2017

  1. 2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination

    Journal of Neuroscience, Vol. 37, Núm. 35, pp. 8385-8398

  2. Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling

    Chemistry - A European Journal, Vol. 23, Núm. 7, pp. 1676-1685

  3. Ligand chain length drives activation of lipid G protein-coupled receptors

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Chemoproteomic approach to explore the target profile of GPCR ligands: Application to 5-HT1A and 5-HT6 receptors

    Chemistry - A European Journal, Vol. 22, Núm. 4, pp. 1313-1321

2015

  1. New inhibitors of angiogenesis with antitumor activity in vivo

    Journal of Medicinal Chemistry, Vol. 58, Núm. 9, pp. 3757-3766

  2. The status of the lysophosphatidic acid receptor type 1 (LPA<inf>1</inf>R)

    MedChemComm, Vol. 6, Núm. 1, pp. 13-23

2014

  1. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis

    Angewandte Chemie - International Edition, Vol. 53, Núm. 50, pp. 13765-13770

  2. The expression of cannabinoid receptor 1 is significantly increased in atopic patients

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 3

2012

  1. Mitochondrial CB 1 receptors regulate neuronal energy metabolism

    Nature Neuroscience, Vol. 15, Núm. 4, pp. 558-564

  2. Chemical probes for the recognition of cannabinoid receptors in native systems

    Angewandte Chemie - International Edition, Vol. 51, Núm. 28, pp. 6896-6899